Wilson Sonsini is a proud sponsor of DHNY. As AI moves into clinical care, the rules governing its use are still taking shape. Wilson Sonsini knows it's important to bring together founders, agency leaders, and regulatory advisors to explore the policy questions shaping AI in healthcare.
On Thursday, September 17 at 2:25pm, Ty Kayam will moderate a panel at the DHNY annual summit.
The Future of AI Policy in Healthcare
Nabil Faizullah
nfaizullah@wsgr.com
Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she advises companies and investors on regulatory strategy for health technology products, with a particular focus on health AI, digital health, wearables, medical robotics, and health data infrastructure. She counsels clients throughout product development and commercialization and advises on health regulatory issues arising in financings, investments, partnerships, and strategic transactions. Her practice draws on experience at the FDA, Microsoft, and a national health information network, combining regulatory insight, technical fluency, and a systems-level understanding of how health technologies are developed, deployed, and scaled.